Cannabinoid hyperemesis syndrome

dc.contributor.authorElnagar, Ali
dc.contributor.authorKgomo, Mpho K.
dc.contributor.authorMokone, Modise
dc.contributor.authorYousif, Badreldin
dc.date.accessioned2024-10-14T09:09:09Z
dc.date.available2024-10-14T09:09:09Z
dc.date.issued2024-04
dc.description.abstractCannabis use is legalised in many countries. We present a patient in their 40s who complained of recurrent abdominal pain and associated nausea and vomiting. The patient was previously seen in various hospitals, treated symptomatically, and discharged with a diagnosis of non-specific abdominal pain. The patient had a chronic history of smoking cannabis and nicotine and drinking alcohol. Abdominal examination revealed no masses, and abdominal X-ray was normal. Blood tests and gastroduodenoscopy revealed no obvious aetiology. Intravenous fluids, together with antiemetics and proton pump inhibitors, were administered. The patient also received counselling and was advised to stop cannabis use. At discharge, the patient was well and asked to come back for review in 2 weeks, and, thereafter monthly for a period of 6 months after stopping cannabis use. The patient reported no recurrent symptoms despite continued cigarette and alcohol use. A suspected cannabinoid hyperemesis syndrome (CHS) became a consideration. Awareness of cannabis-related disorders such as CHS may assist in avoiding costly hospital workups.en_US
dc.description.departmentInternal Medicineen_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.urihttps://casereports.bmj.com/en_US
dc.identifier.citationElnagar, A., Kgomo, M., Mokone, M., et al. Cannabinoid hyperemesis syndrome. BMJ Case Reports 2024;17:e256921. doi:10.1136/bcr-2023-256921.en_US
dc.identifier.issn1757-790X (online)
dc.identifier.other10.1136/bcr-2023- 256921
dc.identifier.urihttp://hdl.handle.net/2263/98581
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.rights© BMJ Publishing Group Limited 2024. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license.en_US
dc.subjectCannabisen_US
dc.subjectAbdominal painen_US
dc.subjectSubstance useen_US
dc.subjectCannabinoid hyperemesis syndrome (CHS)en_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.subjectGastrointestinal systemen_US
dc.subjectGastroenterologyen_US
dc.subjectEndoscopyen_US
dc.subjectPancreatitisen_US
dc.subjectPainen_US
dc.titleCannabinoid hyperemesis syndromeen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Elnagar_Cannabinoid_2024.pdf
Size:
338.83 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: